Phyto-Derived Therapeutic Analogs for Neurological Disorders with Prevalence Insights into Metropolitan and Non-Metropolitan Regions of India: A Review

The field of neurological disorders is a growing public health issue, and India has shown this trend in a very uneven distribution between metropolitan and non-metropolitan areas. Air pollution, chronic stress, sedentary lifestyles, and the availability of better diagnosis have become the causes of reported increasing incidence of stroke, migraine, dementia, and Parkinson's disease among metropolitan population. In contrast, non-metropolitan regions have to experience more prevalence of epilepsy, neuroinfections, neurotrauma, and neurological impairment secondary to malnutrition due to late diagnosis and limited specialist care. The current pharmacological treatments are mostly symptomatic with common side effects and potential lack of disease-modifying effects. Neurotherapeutics derived from plants provide a potential, less expensive and culturally rooted alternative. Established medicinal species, including Withania somnifera, Bacopa monnier have multi-target effects, which are antioxidant, anti-inflammatory, neuroprotective, and neuromodulatory. Because of their extensive use in treatments, their analogs having similar activities must be found, to extend the spectrum of potential neuroprotective agents and reliance on ecologically endangered species is minimized. Further, this review summarises the metropolitan and non-metropolitan neurological disease incidence in India, where the inducers of neurological disorders might be similar but effects may vary due to availability of diagnosis, treatment and various other environmental and societal conditions. The review points out the therapeutic potential of already known plant compounds and their less-studied structural analogs. Through a combination of phytochemical research and a region-specific medical requirement, plant-based molecules may assist in filling diagnostic gaps and offer more accessible and sustainable treatment for neurological conditions in India.

Neurological disorders, Phytochemical analogs, Neuroprotection, Medicinal plants, India

1. Amri, A., Chaumeil, J., Sfar, S., & Charrueau, C. (2011). Administration of resveratrol: What formulation solutions to bioavailability limitations? Journal of Controlled Release, 158(2), 182–193. https://doi.org/10.1016/j.jconrel.2011.09.083 [Google Scholar] [Crossref]

2. Anand, P., Kunnumakkara, A. B., Newman, R. A., & Aggarwal, B. B. (2007). Bioavailability of curcumin: problems and promises. Molecular Pharmaceutics, 4(6), 807–818. https://doi.org/10.1021/mp700113r [Google Scholar] [Crossref]

3. Ansari, S., Maurya, V. K., Kumar, S., Tiwari, M., Abdel-Moneime, A. S., & Saxena, S. K. (2025). Neuroprotective effects of Centella asiatica against LPS/amyloid beta-induced neurodegeneration through inhibition of neuroinflammation. Neuroscience, 575, 19–35. https://doi.org/10.1016/j.neuroscience.2025.04.011 [Google Scholar] [Crossref]

4. Armengol, J. B., Berkov, S., Claveria, L. T., Pigni, N. B., De Andradre, J. P., Martínez, V., Mahrer, C. C., & Meya, F. V. (2011). Chemical and biological aspects of Amaryllidaceae alkaloids. In Transworld Research Network eBooks. http://diposit.ub.edu/dspace/bitstream/2445/21374/1/259113.pdf [Google Scholar] [Crossref]

5. Asl, M. N., & Hosseinzadeh, H. (2008). Review of pharmacological effects of Glycyrrhiza glabra. Phytotherapy Research, 22(6), 709–724. [Google Scholar] [Crossref]

6. Balakrishnan, R., Cho, D. Y., Kim, I. S., Seol, S. H., & Choi, D. K. (2022). Molecular Mechanisms and Therapeutic Potential of α- and β-Asarone in the Treatment of Neurological Disorders. Antioxidants (Basel, Switzerland), 11(2), 281. https://doi.org/10.3390/antiox1102028 [Google Scholar] [Crossref]

7. Balk, D., Montgomery, M. R., Engin, H., Lin, N., Major, E., & Jones, B. D. (2019). Urbanization in India: Population and Urban Classification Grids for 2011. 4(1), 35. https://doi.org/10.3390/DATA4010035 [Google Scholar] [Crossref]

8. Bartels, A. (2011). Blood-Brain barrier P-Glycoprotein function in neurodegenerative disease. Current Pharmaceutical Design, 17(26), 2771–2777. https://doi.org/10.2174/138161211797440122 [Google Scholar] [Crossref]

9. Bavarsad, N. H., Bagheri, S., Kourosh-Arami, M., & Komaki, A. (2023). Aromatherapy for the brain: Lavender’s healing effect on epilepsy, depression, anxiety, migraine, and Alzheimer’s disease: A review article. Heliyon, 9(8), e18492. https://doi.org/10.1016/j.heliyon.2023.e18492 [Google Scholar] [Crossref]

10. Bharti, N. P., Singh, N. M., & Singh, N. a. K. (2023). Role of Ahiphena (Papaver sominiferum) in modern and ancient treatment. Journal of Ayurveda and Integrated Medical Sciences, 8(10), 164–166. https://doi.org/10.21760/jaims.8.10.25 [Google Scholar] [Crossref]

11. Callizot, N., Campanari, M., Rouvière, L., Jacquemot, G., Henriques, A., Garayev, E., & Poindron, P. (2021). Huperzia serrata Extract ‘NSP01’ With Neuroprotective Effects-Potential Synergies of Huperzine A and Polyphenols. Frontiers in Pharmacology, 12, 681532. https://doi.org/10.3389/fphar.2021.681532 [Google Scholar] [Crossref]

12. Cao, Y., Yang, L., & Cheng, H. (2022). Ginkgolide B protects against ischemic stroke via targeting AMPK/PINK1. Frontiers in Pharmacology, 13, 941094. https://doi.org/10.3389/fphar.2022.941094 [Google Scholar] [Crossref]

13. Charlson, F. J., Baxter, A. J., Cheng, H. G., Shidhaye, R., & Whiteford, H. A. (2016). The burden of mental, neurological, and substance use disorders in China and India: a systematic analysis of community representative epidemiological studies. The Lancet, 388(10042), 376-389. [Google Scholar] [Crossref]

14. Cheng, Z., Kang, C., Che, S., Su, J., Sun, Q., Ge, T., Guo, Y., Lv, J., Sun, Z., Yang, W., Li, B., Li, X., & Cui, R. (2022). Berberine: A Promising Treatment for Neurodegenerative Diseases. Frontiers in pharmacology, 13, 845591. https://doi.org/10.3389/fphar.2022.845591 [Google Scholar] [Crossref]

15. Chiang, M. C., Tsai, T. Y., & Wang, C. J. (2023). The Potential Benefits of Quercetin for Brain Health: A Review of Anti-Inflammatory and Neuroprotective Mechanisms. International journal of molecular sciences, 24(7), 6328. https://doi.org/10.3390/ijms24076328 [Google Scholar] [Crossref]

16. Chicca, A., Schafroth, M. A., Reynoso-Moreno, I., Erni, R., Petrucci, V., Carreira, E. M., & Gertsch, J. (2018). Uncovering the psychoactivity of a cannabinoid from liverworts associated with a legal high. Science Advances, 4(10), eaat2166. https://doi.org/10.1126/sciadv.aat2166 [Google Scholar] [Crossref]

17. Chindo, B. A., Adzu, B., & Gamaniel, K. S. (2012). Saponins: structural diversity, properties and applications. Saponins: properties, applications and health benefits, 1-50. [Google Scholar] [Crossref]

18. Chowdhury, D., Krishnan, A., Duggal, A., Amarchand, R., Husøy, A., & Steiner, T. J. (2024). Headache prevalence and demographic associations in the Delhi and National Capital Region of India: estimates from a cross-sectional nationwide population-based study. The Journal of Headache and Pain, 25(1), 108. https://doi.org/10.1186/s10194-024-01814-2 [Google Scholar] [Crossref]

19. Chun, K., Kang, J., Kim, O. H., Kang, H., & Surh, Y. (2002c). Effects of Yakuchinone A and Yakuchinone В on the phorbol Ester-Induced expression of COX-2 and INOS and activation of NF-KB in mouse skin. Journal of Environmental Pathology Toxicology and Oncology, 21(2), 9. https://doi.org/10.1615/jenvironpatholtoxicoloncol.v21.i2.60 [Google Scholar] [Crossref]

20. Dawoud, A. D., & Abdalbagi, M. (2025b). Standardization of Medicinal plants: Ensuring quality, safety, and global regulatory compliance in herbal drug development. Plant Biotechnology Persa, 7(4), 22–23. https://doi.org/10.61882/pbp.7.4.12 [Google Scholar] [Crossref]

21. De Oliveira Koren, L., Lejeune, V. B. P., Baggio, D. F., Da Luz, F. M. R., & Chichorro, J. G. (2024). Effect of peppermint essential oil (Mentha piperita L.) in migraine-like responses in female rats. Headache Medicine/Revista Headache Medicine, 15(2), 78–85. https://doi.org/10.48208/headachemed.2024.17 [Google Scholar] [Crossref]

22. Dhiman, V., Menon, G. R., Kaur, S., Mishra, A., John, D., Vishnu, M. V. R., Tiwari, R. R., & Dhaliwal, U. S. (2021). A systematic review and meta-analysis of prevalence of epilepsy, dementia, headache, and Parkinson disease in India. Neurology India, 69(2), 294–301. https://doi.org/10.4103/0028-3886.314588 [Google Scholar] [Crossref]

23. Dhiman, V., Menon, G.R., Kaur, S., Mishra, A., John, D., Rao Vishnu, M.V., Tiwari, R.R., & Dhaliwal, R.S. (2021). A Systematic Review and Meta-analysis of Prevalence of Epilepsy, Dementia, Headache, and Parkinson Disease in India. Neurology India, 69, 294 - 301. [Google Scholar] [Crossref]

24. Dillon, G. A., Lichter, Z. S., & Alexander, L. M. (2022). Menthol-induced activation of TRPM8 receptors increases cutaneous blood flow across the dermatome. Microvascular Research, 139, 104271. https://doi.org/10.1016/j.mvr.2021.104271 [Google Scholar] [Crossref]

25. Eraiah, M. M., Shekhar, H. C., Joshua, L., & Thomas, J. V. (2024). Effect of Bacopa monnieri Extract on Memory and Cognitive Skills in Adult Humans: A Randomized, Double-Blind, Placebo-Controlled Study. Journal of Psychiatry and Cognitive Behaviour, 8(1). https://doi.org/10.29011/2574-7762.000068 [Google Scholar] [Crossref]

26. Fan, F., & Lei, M. (2022). Mechanisms underlying Curcumin-Induced neuroprotection in cerebral ischemia. Frontiers in Pharmacology, 13, 893118. https://doi.org/10.3389/fphar.2022.893118 [Google Scholar] [Crossref]

27. Farkhondeh, T., Samarghandian, S., Roshanravan, B., & Peivasteh-Roudsari, L. (2019). Impact of curcumin on traumatic brain injury and involved molecular signaling pathways. Recent Patents on Food Nutrition & Agriculture, 11(2), 137–144. https://doi.org/10.2174/2212798410666190617161523 [Google Scholar] [Crossref]

28. Feigin, V. L., Nichols, E., Alam, T., Bannick, M. S., Beghi, E., Blake, N., Culpepper, W. J., Dorsey, E. R., Elbaz, A., Ellenbogen, R. G., Fisher, J. L., Fitzmaurice, C., Giussani, G., Glennie, L., James, S. L., Johnson, C. O., Kassebaum, N. J., Logroscino, G., Marin, B., . . . Car, M. (2019). Global, regional, and national burden of neurological disorders, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. The Lancet Neurology, 18(5), 459–480. https://doi.org/10.1016/s1474-4422(18)30499-x [Google Scholar] [Crossref]

29. Feigin, V. L., Stark, B. A., Johnson, C. O., Roth, G. A., Bisignano, C., Abady, G. G., ... & Hamidi, S. (2021). Global, regional, and national burden of stroke and its risk factors, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019. The Lancet Neurology, 20(10), 795-820. [Google Scholar] [Crossref]

30. Feng, H., Xue, M., Deng, H., Cheng, S., Hu, Y., & Zhou, C. (2022). Ginsenoside and Its Therapeutic Potential for Cognitive Impairment. Biomolecules, 12(9), 1310. https://doi.org/10.3390/biom12091310 [Google Scholar] [Crossref]

31. Ferrari, A. J., Santomauro, D. F., Aali, A., Abate, Y. H., Abbafati, C., Abbastabar, H., ElHafeez, S. A., Abdelmasseh, M., Abd-Elsalam, S., Abdollahi, A., Abdullahi, A., Abegaz, K. H., Zuñiga, R. a. A., Aboagye, R. G., Abolhassani, H., Abreu, L. G., Abualruz, H., Abu-Gharbieh, E., Abu-Rmeileh, N. M., . . . Murray, C. J. L. (2024). Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021. The Lancet, 403(10440), 2133–2161. [Google Scholar] [Crossref]

32. Fraser, P. D., & Bramley, P. M. (2004). The biosynthesis and nutritional uses of carotenoids. Progress in Lipid Research, 43(3), 228–265. [Google Scholar] [Crossref]

33. Fu, P., Guo, X., Cheung, F. M. H., & Yung, K. K. L. (2018). The association between PM2.5 exposure and neurological disorders: A systematic review and meta-analysis. The Science of the Total Environment, 655, 1240–1248. https://doi.org/10.1016/j.scitotenv.2018.11.218 [Google Scholar] [Crossref]

34. Gago, C., Serralheiro, A., & Da Graça Miguel, M. (2025). Anti-Inflammatory activity of thymol and Thymol-Rich essential oils: mechanisms, applications, and recent findings. Molecules, 30(11), 2450. https://doi.org/10.3390/molecules30112450 [Google Scholar] [Crossref]

35. Garodia, P., Hegde, M., Kunnumakkara, A. B., & Aggarwal, B. B. (2023). Curcumin, inflammation, and neurological disorders: How are they linked? Integrative Medicine Research, 12(3), 100968. https://doi.org/10.1016/j.imr.2023.100968 [Google Scholar] [Crossref]

36. Gawrysz, Ż., Cholewa, Z., Derewjanko, S., Gaik, J., Woźniak, J., & Capar, K. (2025). Curcumin as a neuroprotective agent: mechanisms and therapeutic potential in neurodegenerative diseases, acute brain injuries, and neuroinflammation. A review of the literature. Medical Science, 29(163), 1–9. https://doi.org/10.54905/disssi.v29i163.e174ms3680 [Google Scholar] [Crossref]

37. Genchi, G., Lauria, G., Catalano, A., Carocci, A., & Sinicropi, M. S. (2024). Neuroprotective effects of curcumin in neurodegenerative diseases. Foods, 13(11), 1774. https://doi.org/10.3390/foods13111774 [Google Scholar] [Crossref]

38. Georgiev, B., Sidjimova, B., & Berkov, S. (2024). Phytochemical and cytotoxic aspects of Amaryllidaceae alkaloids in Galanthus species: a review. Plants, 13(24), 3577. https://doi.org/10.3390/plants13243577 [Google Scholar] [Crossref]

39. Gościniak, A., Stasiłowicz-Krzemień, A., Szeląg, M., Pawlak, J., Skiera, I., Kwiatkowska, H., Nowak, N., Bernady, K., Trzaskoma, P., Zimak-Krótkopad, O., & Cielecka-Piontek, J. (2025). Bacopa monnieri: Preclinical and Clinical Evidence of Neuroactive Effects, Safety of Use and the Search for Improved Bioavailability. Nutrients, 17(11), 1939. https://doi.org/10.3390/nu17111939 [Google Scholar] [Crossref]

40. Gourie-Devi, M. (2014). Epidemiology of neurological disorders in India: Review of background, prevalence and incidence of epilepsy, stroke, Parkinson′s disease and tremors. Neurology India, 62(6), 588. https://doi.org/10.4103/0028-3886.149365 [Google Scholar] [Crossref]

41. Gourie-Devi, M., Gururaj, G., Satishchandra, P., & Subbakrishna, D. (2004). Prevalence of Neurological Disorders in Bangalore, India: A Community-Based Study with a Comparison between Urban and Rural Areas. Neuroepidemiology, 23(6), 261–268. https://doi.org/10.1159/000080090 [Google Scholar] [Crossref]

42. Hammoud, F., Ismail, A., Zaher, R., El Majzoub, R., & Abou-Abbas, L. (2025). Mucuna pruriens Treatment for Parkinson Disease: A Systematic Review of Clinical Trials. Parkinson's disease, 2025, 1319419. https://doi.org/10.1155/padi/1319419 [Google Scholar] [Crossref]

43. Hedau, V. N., & Patil, T. (2024). Mounting stroke crisis in India: a systematic review. Cureus, 16(3), e57058. https://doi.org/10.7759/cureus.57058 [Google Scholar] [Crossref]

44. Huang, Y., Li, Y., Pan, H., & Han, L. (2023). Global, regional, and national burden of neurological disorders in 204 countries and territories worldwide. Journal of Global Health, 13, 04160. https://doi.org/10.7189/jogh.13.04160 [Google Scholar] [Crossref]

45. Iijima, M., Munakata, R., Takahashi, H., Kenmoku, H., Nakagawa, R., Kodama, T., Asakawa, Y., Abe, I., Yazaki, K., Kurosaki, F., & Taura, F. (2017). Identification and characterization of daurichromenic acid synthase active in Anti-HIV biosynthesis. PLANT PHYSIOLOGY, 174(4), 2213–2230. https://doi.org/10.1104/pp.17.00586 [Google Scholar] [Crossref]

46. Islam, M. T., Ali, E. S., Uddin, S. J., Islam, M. A., Shaw, S., Khan, I. N., Saravi, S. S. S., Ahmad, S., Rehman, S., Gupta, V. K., Găman, M., Găman, A. M., Yele, S., Das, A. K., De Castro E Sousa, J. M., De Moura Dantas, S. M. M., Rolim, H. M. L., De Carvalho Melo-Cavalcante, A. A., Mubarak, M. S., . . . Kamal, M. A. (2018b). Andrographolide, a diterpene lactone from Andrographis paniculata and its therapeutic promises in cancer. Cancer Letters, 420, 129–145. https://doi.org/10.1016/j.canlet.2018.01.074 [Google Scholar] [Crossref]

47. Janardhana, K., Sujatha, B., Nagaraju, K., Prasad, P. V. V., Mohan, M. R., Aruna, D., & ReddyAzizova, P. V. M. (2023). A -Comprehensive Review of Integrating Medicinal Plant Constituents into Neurological Disorder Therapeutics. Journal of Advanced Zoology, 44(S3), 1654–1661. https://doi.org/10.17762/jaz.v44is3.2171 [Google Scholar] [Crossref]

48. Je, G., Arora, S., Raithatha, S.J., Barrette, R., Valizadeh, N., Shah, U.M., Desai, D., Deb, A., & Desai, S.D. (2021). Epidemiology of Parkinson’s Disease in Rural Gujarat, India. Neuroepidemiology, 55, 188 - 195. [Google Scholar] [Crossref]

49. Kashkooe, A., Jalali, A., Zarshenas, M. M., & Hamedi, A. (2024). Exploring the Phytochemistry, Signaling Pathways, and Mechanisms of Action of Tanacetum parthenium (L.) Sch.Bip.: A Comprehensive Literature Review. Biomedicines, 12(10), 2297. https://doi.org/10.3390/biomedicines12102297 [Google Scholar] [Crossref]

50. Kennedy, D., Scholey, A., & Wesnes, K. (2002). Modulation of cognition and mood following administration of single doses of Ginkgo biloba, ginseng, and a ginkgo/ginseng combination to healthy young adults. Physiology & Behavior, 75(5), 739–751. https://doi.org/10.1016/s0031-9384(02)00665-0 [Google Scholar] [Crossref]

51. Khurana, S., & Gourie-Devi, M. (2025). A Narrative review of Community-Based Epidemiological Studies on Parkinson’s Disease in India. Cureus, 17(3), e80248. https://doi.org/10.7759/cureus.80248 [Google Scholar] [Crossref]

52. Kim, S., Venkatesan, J., Rathi, P., & Antony, B. (2023). Pharmacokinetics and bioequivalence of Withania somnifera (Ashwagandha) extracts – A double blind, crossover study in healthy adults. Heliyon, 9(12), e22843. https://doi.org/10.1016/j.heliyon.2023.e22843 [Google Scholar] [Crossref]

53. Kitajima, M., & Takayama, H. (2011). Lycopodium alkaloids: isolation and asymmetric synthesis. Topics in Current Chemistry, 309, 1–31. https://doi.org/10.1007/128_2011_126 [Google Scholar] [Crossref]

54. Kodli, M. V., Raikar, P. K., Kulkarni, P., Kulkarni, U., & Ahmed, K. A. (2025). Strategies to enhance the bioavailability of hydrophilic drugs using natural bioenhancers. Biomedical Materials & Devices. https://doi.org/10.1007/s44174-025-00442-x [Google Scholar] [Crossref]

55. Kumar, C.T., George, S., & Kallivayalil, R.A. (2019). Towards a Dementia-Friendly India. Indian Journal of Psychological Medicine, 41, 476 - 481. [Google Scholar] [Crossref]

56. Kuo, P., Kuo, T., Damu, A. G., Su, C., Lee, E., Wu, T., Shu, R., Chen, C., Bastow, K. F., Chen, T., & Lee, K. (2006). Physanolide A, a Novel Skeleton Steroid, and Other Cytotoxic Principles from Physalis angulata. Organic Letters, 8(14), 2953–2956. https://doi.org/10.1021/ol060801s [Google Scholar] [Crossref]

57. Lane, E. L. (2018). L‐DOPA for Parkinson’s disease—a bittersweet pill. European Journal of Neuroscience, 49(3), 384–398. https://doi.org/10.1111/ejn.14119 [Google Scholar] [Crossref]

58. Lee, J., Park, J. H., Park, O. K., Kim, I. H., Yan, B. C., Ahn, J. H., Kwon, S., Choi, J. H., Kim, J., & Won, M. (2013). Neuroprotective effects of tanshinone I from Danshen extract in a mouse model of hypoxia-ischemia. Anatomy & Cell Biology, 46(3), 183. https://doi.org/10.5115/acb.2013.46.3.183 [Google Scholar] [Crossref]

59. Lee, R., Kim, J. H., Kim, W. W., Hwang, S. H., Choi, S. H., Kim, J. H., Cho, I. H., Kim, M., & Nah, S. Y. (2024). Emerging evidence that ginseng components improve cognition in subjective memory impairment, mild cognitive impairment, and early Alzheimer's disease dementia. Journal of ginseng research, 48(3), 245–252. https://doi.org/10.1016/j.jgr.2024.02.002 [Google Scholar] [Crossref]

60. Lee, T. H., Jung, C. H., & Lee, D. (2012). Neuroprotective effects of Schisandrin B against transient focal cerebral ischemia in Sprague–Dawley rats. Food and Chemical Toxicology, 50(12), 4239–4245. https://doi.org/10.1016/j.fct.2012.08.047 [Google Scholar] [Crossref]

61. Lerose, V., Ponticelli, M., Benedetto, N., Carlucci, V., Lela, L., Tzvetkov, N. T., & Milella, L. (2024). Withania somnifera (L.) Dunal, a Potential Source of Phytochemicals for Treating Neurodegenerative Diseases: A Systematic Review. Plants, 13(6), 771. https://doi.org/10.3390/plants13060771 [Google Scholar] [Crossref]

62. Li, C., Wang, X., Deng, M., Luo, Q., Yang, C., Gu, Z., Lin, S., Luo, Y., Chen, L., Li, Y., & He, B. (2025). Antiepileptic drug combinations for epilepsy: mechanisms, clinical strategies, and future prospects. International Journal of Molecular Sciences, 26(9), 4035. https://doi.org/10.3390/ijms26094035 [Google Scholar] [Crossref]

63. Li, X., Yuan, W., Wu, J., Zhen, J., Sun, Q., & Yu, M. (2022). Andrographolide, a natural anti-inflammatory agent: An Update. Frontiers in Pharmacology, 13, 920435. https://doi.org/10.3389/fphar.2022.920435 [Google Scholar] [Crossref]

64. Liang, K., Ma, S., Luo, K., Wang, R., Xiao, C., Zhang, X., Gao, Y., & Li, M. (2024). Salidroside: An Overview of Its Promising Potential and Diverse Applications. Pharmaceuticals, 17(12), 1703. https://doi.org/10.3390/ph17121703 [Google Scholar] [Crossref]

65. Lin, Z., Cheng, X., & Zheng, H. (2023). Umbelliferon: a review of its pharmacology, toxicity and pharmacokinetics. Inflammopharmacology, 31(4), 1731–1750. https://doi.org/10.1007/s10787-023-01256-3 [Google Scholar] [Crossref]

66. Lu, Y., & Luthria, D. (2014). Influence of postharvest storage, processing, and extraction methods on the analysis of phenolic phytochemicals. In ACS symposium series (pp. 3–31). https://doi.org/10.1021/bk-2014-1185.ch001 [Google Scholar] [Crossref]

67. Ma, X., & Gang, D. R. (2004). The Lycopodium alkaloids. Natural Product Reports, 21(6), 752. https://doi.org/10.1039/b409720n [Google Scholar] [Crossref]

68. Mando, Z., Mando, H., Afzan, A., Shaari, K., Hassan, Z., Mohamad Taib, M. N. A., & Zakaria, F. (2024). Biomarker triterpenoids of Centella asiatica as potential antidepressant agents: Combining in vivo and in silico studies. Behavioural brain research, 466, 114976. https://doi.org/10.1016/j.bbr.2024.114976 [Google Scholar] [Crossref]

69. Meléndez-Martínez, A. J., Mapelli-Brahm, P., Benítez-González, A., & Stinco, C. M. (2015). A comprehensive review on the colorless carotenoids phytoene and phytofluene. Archives of Biochemistry and Biophysics, 572, 188–200. https://doi.org/10.1016/j.abb.2015.01.003 [Google Scholar] [Crossref]

70. Mirjalili, M. H., Moyano, E., Bonfill, M., Cusido, R. M., & Palazón, J. (2009). Steroidal lactones from Physalis and Withania: Structural diversity and bioactivity. Phytochemistry Reviews, 8(2), 401–420. [Google Scholar] [Crossref]

71. Mokra, D., Joskova, M., & Mokry, J. (2022). Therapeutic Effects of Green Tea Polyphenol (‒)-Epigallocatechin-3-Gallate (EGCG) in Relation to Molecular Pathways Controlling Inflammation, Oxidative Stress, and Apoptosis. International journal of molecular sciences, 24(1), 340. https://doi.org/10.3390/ijms24010340 [Google Scholar] [Crossref]

72. Nezhad Salari, A. M., Rasoulizadeh, Z., Shabgah, A. G., Vakili-Ghartavol, R., Sargazi, G., & Gholizadeh Navashenaq, J. (2024). Exploring the mechanisms of kaempferol in neuroprotection: Implications for neurological disorders. Cell biochemistry and function, 42(2), e3964. https://doi.org/10.1002/cbf.3964 [Google Scholar] [Crossref]

73. Olasehinde, T. A., & Olaokun, O. O. (2024). The Beneficial Role of Apigenin against Cognitive and Neurobehavioural Dysfunction: A Systematic Review of Preclinical Investigations. Biomedicines, 12(1), 178. https://doi.org/10.3390/biomedicines12010178 [Google Scholar] [Crossref]

74. Pammi, S. S. (2026). Comparative phytochemical analysis of wild vs. cultivated medicinal plants: Implications for bioactivity. International Journal of Agricultural Sciences and Veterinary Medicine, 3(13), 5. https://doi.org/10.25303/1303ijasvm05019 [Google Scholar] [Crossref]

75. Pandit, S., Srivastav, A. K., Sur, T. K., Chaudhuri, S., Wang, Y., & Biswas, T. K. (2024). Effects of Withania somnifera Extract in Chronically Stressed Adults: A Randomized Controlled Trial. Nutrients, 16(9), 1293. https://doi.org/10.3390/nu16091293 [Google Scholar] [Crossref]

76. Pathak, S., & Godela, R. (2024). Nardostachys jatamansi: Phytochemistry, ethnomedicinal uses, and pharmacological activities: A comprehensive review. Fitoterapia, 172, 105764. https://doi.org/10.1016/j.fitote.2023.105764 [Google Scholar] [Crossref]

77. Piotrowska, H., Kucinska, M., & Murias, M. (2012). Biological activity of piceatannol. Pharmacological Reports, 64(3), 439–450. [Google Scholar] [Crossref]

78. Prabhakar, S., Vishnu, V. Y., Modi, M., Mohanty, M., Sharma, A., Medhi, B., Mittal, B. R., Khandelwal, N., Goyal, M. K., Lal, V., Singla, R., Kansal, A., & Avasthi, A. (2020). Efficacy of Bacopa Monnieri (Brahmi) and Donepezil in Alzheimer's Disease and Mild Cognitive Impairment: A Randomized Double-Blind Parallel Phase 2b Study. Annals of Indian Academy of Neurology, 23(6), 767–773. https://doi.org/10.4103/aian.AIAN_610_19 [Google Scholar] [Crossref]

79. Prakash, J., Chouhan, S., Yadav, S. K., Westfall, S., Rai, S. N., & Singh, S. P. (2014). Withania somnifera Alleviates Parkinsonian Phenotypes by Inhibiting Apoptotic Pathways in Dopaminergic Neurons. Neurochemical Research, 39(12), 2527–2536. https://doi.org/10.1007/s11064-014-1443-7 [Google Scholar] [Crossref]

80. Prema, A., Janakiraman, U., Manivasagam, T., & Thenmozhi, A. J. (2015). Neuroprotective effect of lycopene against MPTP induced experimental Parkinson’s disease in mice. Neuroscience Letters, 599, 12–19. https://doi.org/10.1016/j.neulet.2015.05.024 [Google Scholar] [Crossref]

81. Priyadarsini, K. I. (2014). The chemistry of curcumin: From extraction to therapeutic agent. Molecules, 19(12), 20091–20112. [Google Scholar] [Crossref]

82. Ruankham, W., Suwanjang, W., Wongchitrat, P., Prachayasittikul, V., Prachayasittikul, S., & Phopin, K. (2019). Sesamin and sesamol attenuate H2O2-induced oxidative stress on human neuronal cells via the SIRT1-SIRT3-FOXO3a signaling pathway. Nutritional Neuroscience, 24(2), 90–101. https://doi.org/10.1080/1028415x.2019.1596613 [Google Scholar] [Crossref]

83. Santos, É. R. Q. D., Maia, J. G. S., Fontes-Júnior, E. A., & Maia, C. D. S. F. (2022). Linalool as a therapeutic and medicinal tool in depression treatment: AReview. Current Neuropharmacology, 20(6), 1073–1092. https://doi.org/10.2174/1570159x19666210920094504 [Google Scholar] [Crossref]

84. Santos, J. S. D., Cirino, J. P. G., De Oliveira Carvalho, P., & Ortega, M. M. (2022). The Pharmacological Action of Kaempferol in Central Nervous System Diseases: A Review. Frontiers in Pharmacology, 11, 565700. https://doi.org/10.3389/fphar.2020.565700 [Google Scholar] [Crossref]

85. Semwal, P., Kapoor, T., Anthwal, P., Sati, B., & Thapliyal, A. (2014). Herbal extract as potential modulator and drug for synaptic plasticity and neurodegenerative disorders. Int J Pharm Sci Rev Res, 25(1), 69-79. [Google Scholar] [Crossref]

86. Shaito, A., Al-Mansoob, M., Ahmad, S. M. S., Haider, M. Z., Eid, A. H., Posadino, A. M., Pintus, G., & Giordo, R. (2023). Resveratrol-Mediated Regulation of Mitochondria Biogenesis-associated Pathways in Neurodegenerative Diseases: Molecular Insights and Potential Therapeutic Applications. Current neuropharmacology, 21(5), 1184–1201. https://doi.org/10.2174/1570159X20666221012122855 [Google Scholar] [Crossref]

87. Shan, X., Li, S., Liu, J., Wang, C., Wei, Y., Shi, J., Zhang, X., & Gu, L. (2025). The therapeutic potential of andrographolide and its derivatives in inflammatory diseases. Pharmacology Research & Perspectives, 13(5), e70161. https://doi.org/10.1002/prp2.70161 [Google Scholar] [Crossref]

88. Sharma, S. N. (2025). Understanding Metropolitan Areas and Metropolitan Regions: A Comparative analysis. SSRN Electronic Journal. https://doi.org/10.2139/ssrn.5828564 [Google Scholar] [Crossref]

89. Shen, T., Wang, X., & Lou, H. (2009). Natural stilbenes: an overview. Natural Product Reports, 26(7), 916. https://doi.org/10.1039/b905960a [Google Scholar] [Crossref]

90. Singh, G., Sharma, M., Kumar, G. A., Rao, N. G., Prasad, K., Mathur, P., Pandian, J. D., Steinmetz, J. D., Dua, T., Dandona, L. (2021). The burden of neurological disorders across the states of India: The Global Burden of Disease Study 1990–2019. The Lancet Global Health, 9(8), e1129–e1144. https://doi.org/10.1016/S2214-109X(21)00164-9 [Google Scholar] [Crossref]

91. Singh, S. K., Srivastav, S., Castellani, R. J., Plascencia-Villa, G., & Perry, G. (2019). Neuroprotective and Antioxidant Effect of Ginkgo biloba Extract Against AD and Other Neurological Disorders. Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics, 16(3), 666–674. https://doi.org/10.1007/s13311-019-00767-8 [Google Scholar] [Crossref]

92. Singh, S., Arthur, R., Upadhayay, S., & Kumar, P. (2022). Ferulic acid ameliorates neurodegeneration via the Nrf2/ARE signalling pathway: A Review. Pharmacological Research - Modern Chinese Medicine, 5, 100190. https://doi.org/10.1016/j.prmcm.2022.100190 [Google Scholar] [Crossref]

93. Suvaiv, N., Singh, K., Hasan, S. M., Kumar, A., Khan, A., Shahanawaz, M., Zaidi, S. M. H., & Verma, K. (2025). Huperzine A: a natural acetylcholinesterase inhibitor with multifunctional neuroprotective effects. Beni-Suef University Journal of Basic and Applied Sciences, 14(1). https://doi.org/10.1186/s43088-025-00675-1 [Google Scholar] [Crossref]

94. Tan, S. C., Bhattamisra, S. K., Chellappan, D. K., & Candasamy, M. (2021). Actions and Therapeutic Potential of Madecassoside and Other Major Constituents of Centella asiatica: A Review. Applied Sciences, 11(18), 8475. https://doi.org/10.3390/app11188475 [Google Scholar] [Crossref]

95. Tang, X., Yan, T., Wang, S., Liu, Q., Yang, Q., Zhang, Y., Li, Y., Wu, Y., Liu, S., Ma, Y., & Yang, L. (2023). Treatment with β-sitosterol ameliorates the effects of cerebral ischemia/reperfusion injury by suppressing cholesterol overload, endoplasmic reticulum stress, and apoptosis. Neural Regeneration Research, 19(3), 642–649. https://doi.org/10.4103/1673-5374.380904 [Google Scholar] [Crossref]

96. Tian, E., Sharma, G., & Dai, C. (2023). Neuroprotective Properties of Berberine: Molecular Mechanisms and Clinical Implications. Antioxidants (Basel, Switzerland), 12(10), 1883. https://doi.org/10.3390/antiox12101883 [Google Scholar] [Crossref]

97. Valotto Neto, L. J., Reverete de Araujo, M., Moretti Junior, R. C., Mendes Machado, N., Joshi, R. K., dos Santos Buglio, D., Barbalho Lamas, C., Direito, R., Fornari Laurindo, L., Tanaka, M., & Barbalho, S. M. (2024). Investigating the Neuroprotective and Cognitive-Enhancing Effects of Bacopa monnieri: A Systematic Review Focused on Inflammation, Oxidative Stress, Mitochondrial Dysfunction, and Apoptosis. Antioxidants, 13(4), 393. https://doi.org/10.3390/antiox13040393 [Google Scholar] [Crossref]

98. Varadharajan, A., Davis, A. D., Ghosh, A., Jagtap, T., Xavier, A., Menon, A. J., Roy, D., Gandhi, S., & Gregor, T. (2023). Guidelines for pharmacotherapy in Alzheimer's disease - A primer on FDA-approved drugs. Journal of neurosciences in rural practice, 14(4), 566–573. https://doi.org/10.25259/JNRP_356_2023 [Google Scholar] [Crossref]

99. Vittal, M., & Vinciguerra, M. (2025). Enhancing healthspan with Ashwagandha (Withania somnifera): a comprehensive review of its multifaceted geroprotective benefits. Biogerontology, 26(5), 179. https://doi.org/10.1007/s10522-025-10320-0 [Google Scholar] [Crossref]

100. Wang, L., Chang, T., Zhu, T., Hu, W., Wang, X., Dong, C., Sun, Y., Zhang, T., Jiang, Y., Zhao, C., Cui, Y., Guo, J., & Liao, X. (2025). Stevia rebaudiana Bertoni as a Sweet Herbal Medicine: Traditional Uses, Potential Applications, and Future Development. Frontiers in Pharmacology, 16, 1638147. https://doi.org/10.3389/fphar.2025.1638147 [Google Scholar] [Crossref]

101. Wang, L., Zhao, T., Zhu, X., & Jiang, Q. (2023). Low blood carotenoid status in dementia and mild cognitive impairment: A systematic review and meta-analysis. BMC Geriatrics, 23(1), 195. https://doi.org/10.1186/s12877-023-03900-7 [Google Scholar] [Crossref]

102. Wang, W., & Xu, J. (2020). Curcumin attenuates cerebral ischemia-reperfusion injury through regulating mitophagy and preserving mitochondrial function. Current Neurovascular Research, 17(2), 113–122. https://doi.org/10.2174/1567202617666200225122620 [Google Scholar] [Crossref]

103. Whiteford, H. A., Ferrari, A. J., Degenhardt, L., Feigin, V., & Vos, T. (2015). The global burden of mental, neurological and substance use disorders: an analysis from the Global Burden of Disease Study 2010. PloS one, 10(2), e0116820. https://doi.org/10.1371/journal.pone.0116820 [Google Scholar] [Crossref]

104. Wu, Y., Zhang, J., Wang, D., Liu, J., & Hu, Y. (2013). Triterpenoid saponins from Ziziphus jujuba var. spinosa. Chemistry of Natural Compounds, 49(4), 677–681. https://doi.org/10.1007/s10600-013-0705-y [Google Scholar] [Crossref]

105. Xu, B., Chen, J., & Liu, Y. (2022). Curcumin Interacts with α-Synuclein Condensates To Inhibit Amyloid Aggregation under Phase Separation. ACS omega, 7(34), 30281–30290. https://doi.org/10.1021/acsomega.2c03534 [Google Scholar] [Crossref]

106. Yang, X., & Tohda, C. (2023). Diosgenin restores memory function via SPARC-driven axonal growth from the hippocampus to the PFC in Alzheimer’s disease model mice. Molecular Psychiatry, 28(6), 2398–2411. https://doi.org/10.1038/s41380-023-02052-9 [Google Scholar] [Crossref]

107. Yousaf, M., Chang, D., Liu, Y., Liu, T., & Zhou, X. (2022). Neuroprotection of Cannabidiol, Its Synthetic Derivatives and Combination Preparations against Microglia-Mediated Neuroinflammation in Neurological Disorders. Molecules, 27(15), 4961. https://doi.org/10.3390/molecules27154961 [Google Scholar] [Crossref]

108. Zhang, Y., Huang, Q., Wang, S., Liao, Z., Jin, H., Huang, S., Hong, X., Liu, Y., Pang, J., Shen, Q., Wang, Q., Li, C., & Ji, L. (2022). The food additive Β-Caryophyllene exerts its neuroprotective effects through the JAK2-STAT3-BACE1 pathway. Frontiers in Aging Neuroscience, 14, 814432. https://doi.org/10.3389/fnagi.2022.814432 [Google Scholar] [Crossref]

• The Impact of Ownership Structure on Dividend Payout Policy of Listed Plantation Companies in Sri Lanka
• Urban Sustainability in North-East India: A Study through the lens of NER-SDG index
• Performance Assessment of Predictive Forecasting Techniques for Enhancing Hospital Supply Chain Efficiency in Healthcare Logistics
• The Fractured Self in Julian Barnes' Postmodern Fiction: Identity Crisis and Deflation in Metroland and the Sense of an Ending
• Impact of Flood on the Employment, Labour Productivity and Migration of Agricultural Labour in North Bihar